Shorts

1:06
Cognitive Control for Craving Management
4 months ago
by
Muhammad Parvaz, PhD

1:20
The Power of Collaborative Research
4 months ago
by
Elysia Davis, PhD(+1 more)

0:52
What We Love About Psychiatry
4 months ago
by
Jennie Byrne, MD, PhD

1:15
DSM-6: Putting Profit Over Patient Safety?
4 months ago
by
Allen Frances, MD

1:47
The 4 Stages of Gambling Addiction
4 months ago
by
Asim A. Shah, MD

2:00
Championship-Level Care in Psychiatry
4 months ago
by
Heidi Anne Duerr, MPH

1:31
Latest in Psychedelic Trials for PTSD
4 months ago
by
Gary W. Small, MD

1:11
78% Higher Long COVID Risk: The Mental Health Connection
4 months ago
by
Wael Al-Delaimy, MD, PhD

2:04
Treating Comorbid Personality Disorders
4 months ago
by
Michael Gitlin, MD

1:04
Morning Coffee and Updates: A New and Improved DSM?
4 months ago
by
Leah Kuntz

1:39
DSM Updates: The 4 New Domains Recommended
4 months ago
by
John J. Miller, MD

2:04
Adult vs Child ADHD: What the Data Reveals
4 months ago
by
Douglas Teixeira Leffa, MD, PhD

1:07
Pressure Is a Privilege: A New Look at Mental Health
5 months ago
by
Susan J. Noonan, MD, MPH

1:23
Could Depression Be Treated Like an Immune Disease?
5 months ago
by
Eric J. Nestler, MD, PhD

1:32
ADHD Medication Risks in Pregnancy
5 months ago
by
Timothy Wilens, MD

1:32
ADHD and Pregnancy: Navigating Treatment and Risks
5 months ago
by
Allison S. Baker, MD

1:28
Treating Comorbid ADHD Is Crucial in Patients With Autism
5 months ago
by
Benjamin E. Yerys, PhD

1:07
Genetic Testing for Children With ADHD
5 months ago
by
Ryan Doan, PhD, FACMG

1:15
13% of Adolescents Use AI for Mental Health Advice
5 months ago
by
Jonathan Cantor, PhD

2:38
Microdosing: Patient Expectations and Further Research
5 months ago
by
Joseph F. Goldberg, MD(+1 more)

1:11
Bipolar Diagnostic Challenges and Antidepressant Failure
6 months ago
by
Manish Zinzuvadia, MD

1:32
Reconsidering Antipsychotics for Delirium
6 months ago
by
John J. Miller, MD(+1 more)

1:16
PRiSM Diagnostic Tool: Clinical Writing Opportunity
6 months ago
by
Mark L. Ruffalo, MSW, DPsa

1:19
How Digital Apps Avoid FDA Regulation By Claiming No Medical Intent
7 months ago
by
Jon-Patrick Allem, PhD

1:29
Shifting to the Glutamate Model: Insights from SoFlo Psychiatry
7 months ago
by
Juan D. Oms, MD, FAPA

1:43
New Analysis of Prediction Models for Suicide Risk
7 months ago
by
Seena Fazel, MBChB, MD, FRCPsych

1:08
Treating the Whole Patient With Substance Use Disorder
7 months ago
by
Rachel Rohaidy, MD

0:53
Comorbidities With ADHD to Watch Out For
7 months ago
by
Justin Kei, MD

1:15
Impact of Caplyta FDA Approval, Notes from Roger McIntyre, MD, FRCPC
7 months ago
by
Roger S. McIntyre, MD, FRCPC

1:04
Sex Differences in Pediatric ADHD Presentation
7 months ago
by
Stacy Doumas, MD, MBA
Advertisement
Advertisement
Trending on Psychiatric Times
1
Monoamines: A Full House
2
Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD
3
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
4
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
5
